Issue of Director Shares

AI SummaryClose X

Fusion Antibodies plc has issued 308,720 new ordinary shares at 13 pence per share to executive directors Adrian Kinkaid and Richard Buick, satisfying a portion of their bonuses for the year ended March 31, 2025. This issuance, totaling £40,133.60, is part of a larger fundraising effort announced earlier today. The new shares will be admitted to trading on AIM on January 30, 2026, bringing the total voting rights to 125,021,878.

Disclaimer*

UK 100

Latest directors dealings